跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 835 条关于
“Zelgen Biopharmaceuticals”
全部
835
临床试验
97
药物
226
机构
136
资讯
376
8个月前
AbbVie Secures $1.1B Deal for Zelgen's DLL3-Targeting Cancer Therapy
去年
Ankylosing Spondylitis Pipeline Shows Robust Growth with 20+ Therapies in Development
去年
Spinal Cord Injury and Ankylosing Spondylitis: Advances in Clinical Trials and Therapies
去年
Gecacitinib Shows Superior Efficacy and Safety Over Hydroxyurea in Myelofibrosis Patients
9个月前
Novel Astatine-211 Targeted Alpha Therapy Shows Promise for Radioactive Iodine-Refractory Thyroid Cancer
去年
China Adds 90 Innovative Drugs to National Reimbursement List, Boosting Access to Cancer and Rare Disease Treatments
去年
Thyroid Cancer Pipeline Shows Robust Growth with 50+ Companies Developing Novel Therapies
去年
Gastric Cancer Pipeline Shows Robust Growth with 220+ Therapies in Development Across 200+ Companies
去年
Provectus Biopharmaceuticals Launches VisiRose for Ophthalmic Therapies
去年
Angitia Biopharmaceuticals Doses First Patient in Phase 2 Trial of AGA2118 for Osteoporosis
第 1 页,共 38 页
上一页
下一页